UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 8, 2001
Cytomedix, Inc.
----------------------------------------
(Exact name of registrant as specified in charter)
Delaware 0-28443 23-3011702
-------- ------- ----------
(State of (Commission (IRS Employer
Organization) File Number) Identification No.)
Three Parkway North
Deerfield, Illinois 60015
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's Telephone Number, including area code: (847) 405-7800
--------------
Former name or former address, if changed since last report: Not
applicable
Item 3. Bankruptcy or Receivership
--------------------------
On August 7, 2001, Cytomedix, Inc. (the "Company") filed a
voluntary petition for bankruptcy under Chapter 11 of the U.S.
Bankruptcy Code in the United States Bankruptcy Court of the
Northern District of Illinois, Eastern Division (Case No. 01-
27610). Pursuant to the bankruptcy filing, the Company has
remained in possession of its assets and properties, and the
Company's business and affairs will continue to be managed by the
Company's directors and officers, subject in each case to the
supervision of the Bankruptcy Court.
Item 5. Other Events
------------
Not applicable
Item 7. Financial Statements and Exhibits
---------------------------------
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Unaudited Pro Forma Combined Financial Information.
Not applicable.
(c) Exhibits.
Not applicable.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
Cytomedix, Inc.
By: /s/ James A. Cour
-------------------
James A. Cour
Chief Executive Officer and President
Date: August 8, 2001